Serelaxin improves the therapeutic efficacy of RXFP1-expressing human amnion epithelial cells in experimental allergic airway disease Academic Article uri icon

abstract

  • We have identified combination cell-based therapies that effectively treat the airway inflammation and airway remodelling (structural changes) that contribute to airway obstruction and related airway hyperresponsiveness in murine chronic allergic airways.

authors

  • Royce, SG
  • Tominaga, AM
  • Shen, M
  • Patel, KP
  • Huuskes, Brooke M
  • Lim, R
  • Ricardo, SD
  • Samuel, CS

publication date

  • 2016